Reflector

The chances are slim, but a new resolution in Europe on the subject could drum up support for a Brexit-like scenario.

Not yet, says Reflector. But to judge from the European Parliament's latest foray into the subject, there could be plenty of support for such an approach to this complicated subject.

The UK's Brexit vote has unleashed turbulence in Europe - not least on its pharma sector. Reflector reports.

The UK vote suddenly puts industry on a turbulent track in Europe. The many challenges and effects are outlined here.

Radicals who wield real power at the EMA have gone public with their thinking about the role of regulators in the economic aspects of medicines provision – despite the decades-old EU taboo about linking pricing with authorizations.

Top officials at EMA push the boat out on drug-pricing views.

The dilemma continues: Which medicines should Europe's health systems pay for – and how much should they pay?

Reflector sees both altruism and self-interest in European thinking on neglected diseases.

Altruism and self-interest are at the heart of European thinking on neglected diseases.

A new study spells out the many drug pricing problems in Europe just fine, but fails to address a central access issue-leaving its recommendations frustratingly limited for industry and policymakers.

Europe’s contrasting views on rare disease drugs - one bashing pricing abuses, the other extolling their public health virtues - could ultimately leave these products out in the cold.

As a European politician attacks abuses of the orphan drug scheme, a European report extols its virtues. Reflector asks: in Europe, does the right hand know what the left hand is doing?

What the drug industry stands to gain - or lose - from the unthinkable: Britain departing the European Union.

It's an obvious question for every pharmaceutical executive - and the question no-one dares to answer: what happens if the UK leaves the EU?

The Council of Europe is the latest group to jump into the drug-pricing debate blazing its way through continent.

The Parliamentary Assembly of the Council of Europe is the latest to clamber aboard the well-filled bandwagon now rumbling and rattling across Europe in an increasingly noisy debate over drug prices. Reflector reports.

Some of the radical thinking on healthcare spending from a new EC specialist group offers robust food for thought, writes Reflector.

Reflector outlines the current measures European countries are working or collaborating on to achieve a better understanding of pricing issues.

Adoption of joint procurement agreement signals new effort from EU to better understand drug pricing issues.

France is a striking example of why Europe is still only "edging towards" a genuine universal system

France's bid to regain its influence reveals how far Europe is from fully achieving regulatory convergence, writes Reflector.

The volatility of nation's crisis could pose greater challenges down the line

There are evident challenges for pharma in the ongoing Greek crisis. But, writes Reflector, there are some less evident challenges which may, over time, prove to be more difficult for the industry to cope with.

With Ireland’s signing of a vaccine procurement agreement this month, the EU’s move toward joint action on medicine acquisition is gathering pace, writes Reflector.

Reflector looks at the revitalized European Union directive on patients’ rights in cross-border healthcare.

Edging through the complex terrain that is health technology assessment in Europe

Reflector edges through the complex terrain that is health technology assessment in Europe.

The EU’s proposed new study on off-label prescribing is just another way of kicking the subject into the long grass.

The EU’s proposed new on off-label prescribing is just another way of kicking the issue into the long grass, writes Reflector.

Just as the medicine adaptive pathways to patients (MAPPs) gains currency in the world of medicine, the EU has come up with STAMP, a new expert group intended to assist the process, but which might well suffocate it. Reflector reports.